查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1386356

腦膜炎雙球菌疫苗市場報告：2030 年趨勢、預測與競爭分析

Meningococcal Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

腦膜炎雙球菌疫苗趨勢與預測

2030年，全球腦膜炎雙球菌疫苗市場預計將達到66.6億美元，2024年至2030年的複合年成長率為8.5%。該市場的主要促進因素是腦膜炎盛行率的增加、免疫計劃的擴大以及新疫苗的持續開發。全球腦膜炎球菌疫苗市場的未來看起來充滿希望，零售藥局和醫院藥局市場充滿機會。

腦膜炎雙球菌疫苗市場洞察

Lucintel 預計結合疫苗將在預測期內實現最高成長，因為其具有比多醣疫苗更高的免疫抗原性和更低的反應原性等特徵。

醫院藥房仍然是該市場中最大的部分，因為許多疫苗接種都是在醫院進行的。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2. 未來哪個區隔市場成長較快？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球腦膜炎雙球菌疫苗市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球腦膜炎雙球菌疫苗市場趨勢（2018-2023）與預測（2024-2030）
  • 全球腦膜炎雙球菌疫苗市場（依類型）
    • 多醣
    • 結合疫苗
    • 聯合疫苗
    • 男性B疫苗
    • 其他
  • 全球腦膜炎雙球菌疫苗市場（依最終用途）
    • 零售藥房
    • 醫院藥房
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球腦膜炎雙球菌疫苗市場區域分佈
  • 北美腦膜炎球菌疫苗市場
  • 歐洲腦膜炎雙球菌疫苗市場
  • 亞太腦膜炎雙球菌疫苗市場
  • 其他區域性腦膜炎雙球菌疫苗市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 依類型分類的全球腦膜炎雙球菌疫苗市場成長機會
    • 全球腦膜炎雙球菌疫苗市場成長機會（依最終用途）
    • 全球腦膜炎雙球菌疫苗市場成長機會（依地區）
  • 全球腦膜炎雙球菌疫苗市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 擴大全球腦膜炎雙球菌疫苗市場產能
    • 全球腦膜炎雙球菌疫苗市場的合併、收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Merck
  • Baxter International
  • JN International Medical
  • Biomed
  • Pfizer
  • Glaxosmithkline
  • Serum Institute India
簡介目錄

Meningococcal Vaccine Trends and Forecast

The future of the global meningococcal vaccine market looks promising with opportunities in the retail pharmacy and hospital pharmacy markets. The global meningococcal vaccine market is expected to reach an estimated $6.66 billion by 2030 with a CAGR of 8.5% from 2024 to 2030. The major drivers for this market are growing prevalence of meningitis, expansion of immunization programs, and rising development of new vaccines.

A more than 150-page report is developed to help in your business decisions.

Meningococcal Vaccine by Segment

The study includes a forecast for the global meningococcal vaccine by type, end use, and region.

Meningococcal Vaccine Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Polysaccharide
  • Conjugate Vaccines
  • Combination Vaccines
  • Men B Vaccines
  • Others

Meningococcal Vaccine Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Retail Pharmacies
  • Hospital Pharmacies
  • Others

Meningococcal Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Meningococcal Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies meningococcal vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the meningococcal vaccine companies profiled in this report include-

  • Merck
  • Baxter International
  • JN International Medical
  • Biomed
  • Pfizer
  • GlaxoSmithKline
  • Serum Institute India

Meningococcal Vaccine Market Insights

Lucintel forecasts that conjugate vaccine is expected to witness highest growth over the forecast period due to its features like more immunogenic and less reactogenic than polysaccharide vaccines.

Within this market, hospital pharmacy will remain the largest segment due to the high volume of vaccinations administered in this facility.

Features of the Global Meningococcal Vaccine Market

Market Size Estimates: Meningococcal vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Meningococcal vaccine market size by type, end use, and region in terms of value ($B).

Regional Analysis: Meningococcal vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different types, end uses, and regions for the meningococcal vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the meningococcal vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the meningococcal vaccine market size?

Answer: The global meningococcal vaccine market is expected to reach an estimated 6.66 billion by 2030.

Q.2 What is the growth forecast for meningococcal vaccine market?

Answer: The global meningococcal vaccine market is expected to grow with a CAGR of 8.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the meningococcal vaccine market?

Answer: The major drivers for this market are growing prevalence of meningitis, expansion of immunization programs, and rising development of new vaccines.

Q4. What are the major segments for meningococcal vaccine market?

Answer: The future of the meningococcal vaccine market looks promising with opportunities in the retail pharmacy and hospital pharmacy markets.

Q5. Who are the key meningococcal vaccine market companies?

Answer: Some of the key meningococcal vaccine companies are as follows:

  • Merck
  • Baxter International
  • JN International Medical
  • Biomed
  • Pfizer
  • GlaxoSmithKline
  • Serum Institute India

Q6. Which meningococcal vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that conjugate vaccine is expected to witness highest growth over the forecast period due to its features like more immunogenic and less reactogenic than polysaccharide vaccines.

Q7. In meningococcal vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to high prevalence of meningococcal disease among adolescents and young adults in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the meningococcal vaccine market by type (polysaccharide, conjugate vaccines, combination vaccines, men B vaccines, and others), end use (retail pharmacies, hospital pharmacies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Meningococcal Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Meningococcal Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Meningococcal Vaccine Market by Type
    • 3.3.1: Polysaccharide
    • 3.3.2: Conjugate Vaccines
    • 3.3.3: Combination Vaccines
    • 3.3.4: Men B Vaccines
    • 3.3.5: Others
  • 3.4: Global Meningococcal Vaccine Market by End Use
    • 3.4.1: Retail Pharmacies
    • 3.4.2: Hospital Pharmacies
    • 3.4.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Meningococcal Vaccine Market by Region
  • 4.2: North American Meningococcal Vaccine Market
    • 4.2.2: North American Meningococcal Vaccine Market by End Use: Retail Pharmacies, Hospital Pharmacies, and Others
  • 4.3: European Meningococcal Vaccine Market
    • 4.3.1: European Meningococcal Vaccine Market by Type: Polysaccharide, Conjugate Vaccines, Combination Vaccines, Men B Vaccines, and Others
    • 4.3.2: European Meningococcal Vaccine Market by End Use: Retail Pharmacies, Hospital Pharmacies, and Others
  • 4.4: APAC Meningococcal Vaccine Market
    • 4.4.1: APAC Meningococcal Vaccine Market by Type: Polysaccharide, Conjugate Vaccines, Combination Vaccines, Men B Vaccines, and Others
    • 4.4.2: APAC Meningococcal Vaccine Market by End Use: Retail Pharmacies, Hospital Pharmacies, and Others
  • 4.5: ROW Meningococcal Vaccine Market
    • 4.5.1: ROW Meningococcal Vaccine Market by Type: Polysaccharide, Conjugate Vaccines, Combination Vaccines, Men B Vaccines, and Others
    • 4.5.2: ROW Meningococcal Vaccine Market by End Use: Retail Pharmacies, Hospital Pharmacies, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Meningococcal Vaccine Market by Type
    • 6.1.2: Growth Opportunities for the Global Meningococcal Vaccine Market by End Use
    • 6.1.3: Growth Opportunities for the Global Meningococcal Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Meningococcal Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Meningococcal Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Meningococcal Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Merck
  • 7.2: Baxter International
  • 7.3: JN International Medical
  • 7.4: Biomed
  • 7.5: Pfizer
  • 7.6: Glaxosmithkline
  • 7.7: Serum Institute India